Skip to content
Back to News
ArticleBy Record desk

The 1999 thimerosal decision: when federal agencies first acted on mercury in vaccines

Why it matters

Reform advocates point to 1999 as the moment the government itself conceded there was a mercury-exposure problem worth acting on, the historical foundation of the modern causation argument.

Aged medical journals and vaccine vials under a desk lamp

In 1999, the FDA determined that cumulative mercury exposure from thimerosal-containing childhood vaccines could exceed federal safety guidelines for infants. In July 1999, the American Academy of Pediatrics and the U.S. Public Health Service issued a joint statement recommending thimerosal be removed from vaccines as a precaution.

In 2000, the CDC convened the Simpsonwood conference to review Vaccine Safety Datalink data on possible links between thimerosal and neurodevelopmental disorders, a meeting that reform advocates, including Robert F. Kennedy Jr. in his later writing, have cited as pivotal.

Mainstream science holds that subsequent research found no association between thimerosal and autism. That 1999–2000 record is where this story really starts: the documented moment federal agencies acted first and argued the science afterward.

Source

AJF reporting.

More from

Related coverage

A presidential desk with a signed document, a fountain pen, and an American flag out of focusPost
AJF Original

“Kennedy is the saving grace”: Trump moves to remake the childhood schedule, and what is actually in force

In the span of six weeks the President signed an order cutting routine childhood vaccines from 18 diseases to 11, then stood beside Robert F. Kennedy Jr. and proposed splitting shots into five smaller doses. A viral clip called it a schedule of 72 shots reduced to 11 “by the stroke of a pen.” That is the biggest shift in federal vaccine posture in a generation, and it is also not yet law. Here is the record, and the reaction, side by side.